Wells Fargo analyst Gabrial Hajde maintains $AptarGroup (ATR.US)$ with a buy rating, and adjusts the target price from $168 to $185.
According to TipRanks data, the analyst has a success rate of 57.4% and a total average return of 4.3% over the past year.
Furthermore, according to the comprehensive report, the opinions of $AptarGroup (ATR.US)$'s main analysts recently are as follows:
Ahead of quarterly results in the packaging and containers sector, there is an anticipation that Q3 demand has seen a sequential improvement. However, a dramatic uptick is not expected due to prevailing cautious sentiment among consumers and industrial sectors. It is suggested the most challenging period has passed, but expectations are tempered with a projection of flat volume trends rather than a low single-digit increase for the year. A recovery is thought to be more likely during the first half of 2025.
AptarGroup's Pharma segment is anticipated to drive an 8.5% annual EBITDA growth through 2026, bolstered by a robust pipeline of new products including delivery systems for GLP-1 drugs, over-the-counter Narcan, and Neffy. This growth trajectory is expected to align the company's valuation more closely with its peers in the healthcare packaging sector.
Note:
TipRanks, an independent third party, provides analysis data from financial analysts and calculates the Average Returns and Success Rates of the analysts' recommendations. The information presented is not an investment recommendation and is intended for informational purposes only.
Success rate is the number of the analyst's successful ratings, divided by his/her total number of ratings over the past year. A successful rating is one based on if TipRanks' virtual portfolio earned a positive return from the stock. Total average return is the average rate of return that the TipRanks' virtual portfolio has earned over the past year. These portfolios are established based on the analyst's preliminary rating and are adjusted according to the changes in the rating.
TipRanks provides a ranking of each analyst up to 5 stars, which is representative of all recommendations from the analyst. An analyst's past performance is evaluated on a scale of 1 to 5 stars, with more stars indicating better performance. The star level is determined by his/her total success rate and average return.
富国集团分析师Gabrial Hajde维持$AptarGroup (ATR.US)$买入评级，并将目标价从168美元上调至185美元。
根据TipRanks数据显示，该分析师近一年总胜率为57.4%，总平均回报率为4.3%。
此外，综合报道，$AptarGroup (ATR.US)$近期主要分析师观点如下：
在包装和容器行业公布季度业绩之前，预计第三季度的需求将连续改善。但是，由于消费者和工业部门普遍持谨慎情绪，预计不会出现大幅上涨。据称，最具挑战性的时期已经过去，但由于预测全年销量呈平稳趋势，而不是较低的个位数增长，预期受到抑制。据认为，2025年上半年复苏的可能性更大。
预计到2026年，AptarGroup的制药板块将推动8.5％的年度息税折旧摊销前利润增长，这得益于包括 GLP-1 药物递送系统、非处方Narcan和Neffy在内的强大新产品管线。预计这一增长轨迹将使该公司的估值与医疗包装领域的同行更加接近。
提示:
TipRanks为独立第三方，提供金融分析师的分析数据，并计算分析师推荐的平均回报率和胜率。提供的信息并非投资建议，仅供参考。本文不对评级数据和报告的完整性与准确性做出认可、声明或保证。
TipRanks提供每位分析师的星级，分析师星级代表分析师所有推荐的过往表现，通过分析师的总胜率和平均回报率综合计算得出，星星越多，则该分析师过往表现越优异，最高为5颗星。
分析师总胜率为近一年分析师的评级成功次数占总评级次数的比率。评级的成功与否，取决于TipRanks的虚拟投资组合是否从该股票中产生正回报。
总平均回报率为基于分析师的初始评级创建虚拟投资组合，并根据评级变化对组合进行调整，在近一年中该投资组合所获得的回报率。
